Covered recipient · General Payments record
REID S CHRISTOPHER
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,119.93
- Reported across 168 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $398.88 | 22 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $144.74 | 8 |
| Amgen Inc. | $55.71 | 3 |
| Lilly USA, LLC | $39.74 | 2 |
| Acerta Pharma LLC | $34.67 | 2 |
| PFIZER INC. | $31.44 | 2 |
| GlaxoSmithKline, LLC. | $31.37 | 2 |
| Abbott Laboratories | $21.85 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.28 | 1 |
| Esperion Therapeutics, Inc. | $19.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (22)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $21.85 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125369658 | CMS |
| Amgen Inc. | $23.75 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117527215 | CMS |
| Amgen Inc. | $16.92 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117527217 | CMS |
| Amgen Inc. | $15.04 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117527219 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.63 | 03/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110542671 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.04 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110546111 | CMS |
| Esperion Therapeutics, Inc. | $19.08 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129431192 | CMS |
| GlaxoSmithKline, LLC. | $15.53 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116506919 | CMS |
| GlaxoSmithKline, LLC. | $15.84 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116583945 | CMS |
| Lilly USA, LLC | $18.23 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135373654 | CMS |
| Lilly USA, LLC | $21.51 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135373656 | CMS |
| Novo Nordisk Inc | $13.43 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108579219 | CMS |
| Novo Nordisk Inc | $14.64 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108576873 | CMS |
| Novo Nordisk Inc | $6.25 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108576118 | CMS |
| Novo Nordisk Inc | $23.35 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108574506 | CMS |
| Novo Nordisk Inc | $18.30 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108575926 | CMS |
| Novo Nordisk Inc | $24.75 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108576671 | CMS |
| Novo Nordisk Inc | $18.10 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108577973 | CMS |
| Novo Nordisk Inc | $25.92 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108575902 | CMS |
| PFIZER INC. | $15.08 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131049765 | CMS |
| PFIZER INC. | $16.36 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132094146 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.28 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137512722 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.